Trial · NCT01670656
Adverse events30
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 30
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Headache | Nervous system disorders | NOMAC-E2 (700/300 mcg) | 9 | 86 | 13 |
| other | Headache | Nervous system disorders | NOMAC-E2 (900/300 mcg) | 9 | 91 | 19 |
| other | Headache | Nervous system disorders | ENG-E2 (100/300 mcg) | 11 | 86 | 13 |
| other | Headache | Nervous system disorders | ENG-E2 (125/300 mcg) | 5 | 85 | 7 |
| other | Headache | Nervous system disorders | Placebo | 7 | 90 | 9 |
| other | Breast pain | Reproductive system and breast disorders | NOMAC-E2 (700/300 mcg) | 5 | 86 | 7 |
| other | Breast pain | Reproductive system and breast disorders | NOMAC-E2 (900/300 mcg) | 1 | 91 | 1 |
| other | Breast pain | Reproductive system and breast disorders | ENG-E2 (100/300 mcg) | 1 | 86 | 1 |
| other | Breast pain | Reproductive system and breast disorders | ENG-E2 (125/300 mcg) | 1 | 85 | 1 |
| other | Breast pain | Reproductive system and breast disorders | Placebo | 2 | 90 | 3 |
| other | Acne | Skin and subcutaneous tissue disorders | NOMAC-E2 (700/300 mcg) | 1 | 86 | 1 |
| other | Acne | Skin and subcutaneous tissue disorders | NOMAC-E2 (900/300 mcg) | 1 | 91 | 1 |
| other | Acne | Skin and subcutaneous tissue disorders | ENG-E2 (100/300 mcg) | 2 | 86 | 2 |
| other | Acne | Skin and subcutaneous tissue disorders | ENG-E2 (125/300 mcg) | 1 | 85 | 1 |
| other | Acne | Skin and subcutaneous tissue disorders | Placebo | 5 | 90 | 7 |
| serious | Appendicitis | Infections and infestations | NOMAC-E2 (700/300 mcg) | 0 | 86 | 0 |
| serious | Appendicitis | Infections and infestations | NOMAC-E2 (900/300 mcg) | 0 | 91 | 0 |
| serious | Appendicitis | Infections and infestations | ENG-E2 (100/300 mcg) | 0 | 86 | 0 |
| serious | Appendicitis | Infections and infestations | ENG-E2 (125/300 mcg) | 1 | 85 | 1 |
| serious | Appendicitis | Infections and infestations | Placebo | 0 | 90 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01670656/events